2017年1期
刊物介紹
本刊主要是及時報道我國在腫瘤防治研究領域包括癌癥基礎理論研究和癌癥預防、臨床治療研究方面的新進展、新成果，內容涉及腫瘤病因學與滸病學，實驗腫瘤學、腫瘤細胞分子生物學，腫瘤病理學以及腫瘤影像診斷、腫瘤外科治療、化學治療、放射治療、介入治療、生物治療和中西醫(yī)結合治療腫瘤等各分支學科，旨在促進國內外學術交流，提高我國癌癥研究與癌癥治療水平。
Chinese Journal of Cancer Research
Original Article
- Cancer incidence and mortality in China in 2013: an analysis based on urbanization level
- Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
- Extranodal involvement in young patients with diffuse large B-cell lymphoma: distribution, prognostic value and treatment options
- PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma
- Influencing factors of inpatient expenditure pattern for cancer in China, 2015
- Prognostic factors for transarterial chemoembolization combined with sustained oxaliplatin-based hepatic arterial infusion chemotherapy of colorectal cancer liver metastasis
- Upregulation of kazrin F by miR-186 suppresses apoptosis but promotes epithelial-mesenchymal transition to contribute to malignancy in human cervical cancer cells
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis